An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
The endovascular strategy did not significantly reduce mortality at 30 days, but by 3 years there did appear to be QALY gains and a possible survival advantage.
1 Vascular Surgery Research Group, Imperial College London, London, UK
2 Bristol Centre for Surgical Research, Department of Surgical Sciences, University of Bristol, Bristol, UK
3 Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
4 Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK
5 Vascular Surgery, St George’s Hospital, London, UK
6 Department of Radiology, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK
* Corresponding author Email: j.powell@imperial.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document